Early Prone Position on Coronavirus Disease 2019 Pneumonia

Sponsor
Sisli Hamidiye Etfal Training and Research Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04427969
Collaborator
(none)
33
1
15
67

Study Details

Study Description

Brief Summary

the purpose of this study to evaluate the effect of early awake PP (prone position)application on oxygenation and intubation requirement in patients with acute respiratory failure due to coronavirus disease 2019 pneumonia.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: prone position

Detailed Description

The first group (early prone position-EPP) created for our study was composed of patients who received PP at least 12 hours early (with the first 48 hours) with the oxygen support of the reservoir mask, and the second group (non-EPP ) patients who received oxygen with the reservoir mask but could not be applied early PP due to the patient's incompatibility or rejection.

Conventional oxygen therapy applied to all patients was given with a reservoir mask, aiming at oxygen saturation 93% and above, at a flow rate of 6-15 L / min.

Despite all the treatments, the patients who have a follow-up with a respiratory acidosis , oxygen saturation value below 93%, applied non invasive mechanical ventilation, in case of insufficient patient intubated and have invasive mechanical ventilation. In patients who had regression of glasgow coma scale during follow-up, orotracheal intubation was performed and invasive mechanical ventilation was performed.

Study Design

Study Type:
Observational
Actual Enrollment :
33 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
The Effect of Early Prone Position on Prognosis in Acute Respiratory Failure Due to Coronavirus Disease 2019 Pneumonia
Actual Study Start Date :
Jun 15, 2020
Actual Primary Completion Date :
Jun 25, 2020
Actual Study Completion Date :
Jun 30, 2020

Arms and Interventions

Arm Intervention/Treatment
EPP

patients who applied early awake prone position for treatment with conventional oxygen supply

Behavioral: prone position
to lay in prone position at least 12 hour in a day at ICU

non-EPP

patient who only get conventional oxygen therapy as respiratory supply

Outcome Measures

Primary Outcome Measures

  1. intensive care unit stay [up to 28 days]

    the duration of icu stay day

  2. short term mortality [up to 28 days]

    mortality percent

Secondary Outcome Measures

  1. blood gases [up to 24 hours]

    partial oxygen pressure: mmhg , partial carbondiocsit pressure mmhg

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients who developed acute respiratory failure due to coronavirus disease 2019 pneumonia

  • received conventional oxygen therapy with reservoir mask oxygen at the stage of admission to the intensive care unit

  • older than 18 years old

Exclusion Criteria:
  • patients with respiratory acidosis,

  • partial oxygen pressure/fraction of inspired oxygen ratio below 150,

  • Glasgow Coma Score (GKS) below 12 points,

  • hemodynamic instability,

  • primary pulmonary pathologies other than pneumonia (lung cancer, cardiopulmonary edema, carcinogen syndrome, etc.)

  • patients who underwent non-invasive mechanical ventilation(NIMV) or intubated from admission to intensive care,

  • those who underwent self prone position under 12 hours were not included in the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sisli Etfal Research and Training Hospital Istanbul Marmara Turkey 34400

Sponsors and Collaborators

  • Sisli Hamidiye Etfal Training and Research Hospital

Investigators

  • Study Chair: ayse surhan cinar, chief of anesthesia department

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Mustafa Altınay, spercialist medical doctor, Sisli Hamidiye Etfal Training and Research Hospital
ClinicalTrials.gov Identifier:
NCT04427969
Other Study ID Numbers:
  • pp34
First Posted:
Jun 11, 2020
Last Update Posted:
Nov 10, 2020
Last Verified:
Nov 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mustafa Altınay, spercialist medical doctor, Sisli Hamidiye Etfal Training and Research Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 10, 2020